Serum Antibody Identifies a Potassium Channel as an Immune Target in Multiple Sclerosis
Multiple sclerosis is a complex and chronic inflammatory disease of the central nervous system that causes damage to the myelin sheath surrounding neu...
Abnormal Plasma Apolipoprotein Levels Linked to Cognitive Decline
A mounting body of evidence is linking cardiovascular risk factors, including atherosclerosis, hypertension, and cholesterol levels, with Alzheimer's...
Do Biomarkers for Traumatic Brain Injury Overlap with Other Neurodegenerative Disorders?
A Swedish group of researchers has published a study taking a look at CSF biomarkers following repetitive head trauma. After collecting samples from O...
Major Depression and Alzheimer’s Disease: A common link?
The association between depression and AD is not new but a new article published in The American Journal of Psychiatry offers a look into one possible...
Blood-based or CSF-based?
Do you think drug development groups and clinical researchers would rather have a biomarker discovery tool for neurodegenerative disease that is blood...
How soon do Alzheimer’s biomarkers start taking their toll?
Currently, hopes of preventing the worst of the decline seen with Alzheimer's disease lie in the early detection or identifying those who are predispo...
Biomarkers Should Be Included in More Clinical Trials for Alzheimer’s
Last week, a panel of Alzheimer's disease researchers and thought leaders from the Alzheimer's Disease Biomarker Expert Working Group published their...